Drug profile

The FDA adverse-event record for Leptospira-Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

151 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Leptospira-Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract. See the species affected, top reactions, and outcomes below.

151
adverse-event reports
9.9%
death-coded share
Dog
most-reported species
51
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
151
Total Reports
15
Deaths Reported
9.9%
Death Rate

Active Ingredients

Leptospira-Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

Administration Routes

SubcutaneousParenteralUnknownOralOther

Species Affected

Dog 151

Most Affected Breeds

Retriever - Labrador 16
Shih Tzu 13
Retriever - Golden 10
Chihuahua 9
Shepherd Dog - Australian 6
Crossbred Canine/dog 5
Maltese 4
Bulldog - French 4
Pit Bull 4
Terrier - Yorkshire 4

Most Reported Reactions

Vomiting 51
Lethargy (see also Central nervous system depression in 'Neurological') 29
Other abnormal test result NOS 20
Elevated alanine aminotransferase (ALT) 13
Not eating 13
Leucocytosis NOS 13
Lethargy (see also Central nervous system depression in Neurological) 13
Abnormal ultrasound finding 11
Death 11
Neutrophilia 11
Lack of efficacy - NOS 11
Anorexia 10

Outcome Breakdown

Recovered/Normal
53 (35.1%)
Outcome Unknown
43 (28.5%)
Ongoing
40 (26.5%)
Died
11 (7.3%)
Euthanized
4 (2.6%)

Leptospira-Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract Adverse Event Insights

151 reports name Leptospira-Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract; 15 recorded a death outcome (9.9% of reported events, not a population-level mortality rate). Active ingredient: Leptospira-Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract. Administration routes: Subcutaneous, Parenteral, Unknown, Oral.

By species: Dog (151 reports). By breed: Retriever - Labrador (16), Shih Tzu (13), Retriever - Golden (10).

Leading clinical signs: Vomiting (51), Lethargy (see also Central nervous system depression in 'Neurological') (29), Other abnormal test result NOS (20), Elevated alanine aminotransferase (ALT) (13). Outcome, 151 coded reports: Recovered/Normal leads at 35.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.